Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
41
KPTI Quote, Financials, Valuation and Earnings
Last price:
$4.33
Seasonality move
:
-11.48%
Day range:
$4.30 - $4.55
52-week range:
$3.51 - $17.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.28x
P/B ratio:
--
Volume:
27.4K
Avg. volume:
81.5K
1-year change:
-68.36%
Market cap:
$39.2M
Revenue:
$145.2M
EPS (TTM):
-$13.27
Earnings Data
Next earnings date for KPTI
Aug 06
2025
Most recent earnings per share
-$2.77
Beat by $0.32
(May 12/2025)
Consensus Estimate
-$3.09
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KPTI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/06/2025 | Q2 | $37.9M | -- | -- | -$4.00 | -- |
| 05/12/2025 | Q1 | $35.1M | $30M | -$2.77 | -$3.09 | $0.32 |
| 02/19/2025 | Q4 | $35.7M | $30.5M | -$3.60 | -$4.03 | $0.43 |
| 11/05/2024 | Q3 | $37.9M | $38.8M | -$3.90 | -$3.93 | $0.02 |
| 08/06/2024 | Q2 | $36.2M | $42.8M | -$3.00 | -$4.47 | $1.47 |
| 05/08/2024 | Q1 | $34.5M | $33.1M | -$4.80 | -$4.94 | $0.14 |
| 02/29/2024 | Q4 | $33.6M | $33.7M | -$5.40 | -$4.65 | -$0.75 |
| 11/02/2023 | Q3 | $36.9M | $36M | -$4.50 | -$4.29 | -$0.21 |
| 08/02/2023 | Q2 | $35.7M | $37.6M | -$4.35 | -$5.04 | $0.69 |
| 05/04/2023 | Q1 | $36.3M | $38.7M | -$4.50 | -$5.23 | $0.73 |
| 02/15/2023 | Q4 | -- | $33.6M | -$6.45 | -- | -- |
| 11/03/2022 | Q3 | -- | $36.1M | -$6.75 | -- | -- |
| 08/04/2022 | Q2 | -- | $39.7M | -$9.30 | -- | -- |
| 05/05/2022 | Q1 | -- | $47.7M | -$7.95 | -- | -- |
| 02/08/2022 | Q4 | -- | $126.3M | $6.90 | -- | -- |
| 11/03/2021 | Q3 | -- | $37.7M | -$10.35 | -- | -- |
| 08/05/2021 | Q2 | -- | $22.6M | -$10.65 | -- | -- |
| 05/03/2021 | Q1 | -- | $23.3M | -$11.55 | -- | -- |
| 02/11/2021 | Q4 | -- | $35.1M | -$8.85 | -- | -- |
| 11/02/2020 | Q3 | -- | $21.3M | -$10.95 | -- | -- |
| 08/04/2020 | Q2 | -- | $33.5M | -$9.45 | -- | -- |
| 05/08/2020 | Q1 | -- | $18.1M | -$11.70 | -- | -- |
| 02/13/2020 | Q4 | -- | $18.1M | -$11.40 | -- | -- |
| 11/04/2019 | Q3 | -- | $13.1M | -$10.05 | -- | -- |
| 08/06/2019 | Q2 | -- | $9.5M | -$10.65 | -- | -- |
| 05/09/2019 | Q1 | -- | $155K | -$16.35 | -- | -- |
| 02/28/2019 | Q4 | -- | $206K | -$14.40 | -- | -- |
| 11/08/2018 | Q3 | -- | $239K | -$11.85 | -- | -- |
| 08/07/2018 | Q2 | -- | $19.9M | -$9.00 | -- | -- |
| 05/10/2018 | Q1 | -- | $10M | -$11.70 | -- | -- |
| 03/15/2018 | Q4 | -- | $1.5M | -$12.00 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$9.75 | -- | -- |
| 08/08/2017 | Q2 | -- | $3K | -$9.60 | -- | -- |
| 05/04/2017 | Q1 | -- | $68K | -$10.65 | -- | -- |
| 03/16/2017 | Q4 | -- | $47K | -$9.75 | -- | -- |
| 11/07/2016 | Q3 | -- | $48K | -$10.35 | -- | -- |
| 08/04/2016 | Q2 | -- | $59K | -$12.60 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$11.25 | -- | -- |
| 03/14/2016 | Q4 | -- | $25K | -$12.15 | -- | -- |
| 11/09/2015 | Q3 | -- | $75K | -$12.75 | -- | -- |
| 08/10/2015 | Q2 | -- | $150K | -$13.80 | -- | -- |
Karyopharm Therapeutics Earnings Questions
-
How Much did Karyopharm Therapeutics Generate in Revenue Last Quarter?
Karyopharm Therapeutics reported $30M worth of top line sales in its most recent quarter.
-
Did Karyopharm Therapeutics Beat Earnings Last Quarter?
Karyopharm Therapeutics announced earnings per share of -$2.77 which represents a beat of analyst forecast a -$3.09 per share.
-
Is Karyopharm Therapeutics Profitable?
Karyopharm Therapeutics reported $28.7M that represents $3.39 per share over the last quarter.
-
What is the Analyst Consensus for Karyopharm Therapeutics EPS Next Year?
Karyopharm Therapeutics's earnings are forecast to decrease from -$13.95 per share to -$9.23 per share next year representing a decrease of -36.7%.
-
When is Karyopharm Therapeutics's Earnings Date?
Karyopharm Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.
Buy
75
ARQQ alert for Jun 17
Arqit Quantum [ARQQ] is up 6.36% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 3.91% over the past day.
